Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chimeric Antigen Receptor Engineered Stem Cells: A Novel HIV Therapy

1 Mar 2017

Abstract excerpt

Despite the success of combination antiretroviral therapy (cART) for suppressing HIV and improving patients' quality of life, HIV persists in cART-treated patients and remains an incurable disease. Financial burdens and health consequences of lifelong cART treatment call for novel HIV therapies that result in a permanent cure. Cellular immunity is central in controlling HIV replication. However, HIV adopts...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to RNA Interference and Gene Delivery
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28357916
DOI: 10.2217/imt-2016-0121

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chimeric Antigen Receptor Engineered Stem Cells: A Novel HIV TherapyPMID 28357916Read ↗

Advances in Developing CAR T-Cell Therapy for HIV CureSemantic proximity Read ↗

Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T CellsSemantic proximity Read ↗

Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance anti-HIV activity in vitroSemantic proximity Read ↗

Chimeric Antigen Receptors: A Paradigm Shift in ImmunotherapySemantic proximity Read ↗

Robust CAR-T memory formation and function via hematopoietic stem cell deliverySemantic proximity Read ↗

Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic AntibodiesSemantic proximity Read ↗

Emerging Cellular Therapies for CancerSemantic proximity Read ↗

Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.Semantic proximity Read ↗

Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineeringSemantic proximity Read ↗

Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infectionSemantic proximity Read ↗

Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 LocusSemantic proximity Read ↗

Chimeric antigen receptor-modified T cells strike backSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.